Mohamed S. Alesawy - Concepedia

Author

Mohamed S. Alesawy

Al-Azhar University ORCID

Also Known As

Mohamed S. Alesawy, Mohammed S.I. Alesawy

Publications

875

Citations

H-Index

Concepts

All Affiliations

Al-Azhar University Alfaisal University Almaarefa University City of Scientific Research and Technological Applications Princess Nourah bint Abdulrahman University

About

Mohamed S. Alesawy is an author at Al-Azhar University specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	367
2	Natural Sciences	2	2	95
3	Biomolecular Engineering	2	2	102
4	Engineering	1	1	59
5	Biochemistry	1	1	84

Mohamed S. Alesawy

Publications

860

Citations

H-Index

Page 1

	Year	Citations
Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: <i>in-vitro</i> anticancer evaluation and <i>in-silico</i> studies Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, Journal of Enzyme Inhibition and Medicinal Chemistry	2022	93
Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2 Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, Bioorganic Chemistry Medicinal ChemistryDrug TargetingMedicineRational Drug DesignAnti-cancer Agent	2022	86
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists Mohamed K. Ibrahim, Ibrahim H. Eissa, Mohamed S. Alesawy, Bioorganic & Medicinal Chemistry Molecular PharmacologyPotential PparγPharmaceutical ChemistryBiochemistryMedicine	2017	84
Design and discovery of new 1,2,4‐triazolo[4,3‐<i>c</i>]quinazolines as potential DNA intercalators and topoisomerase II inhibitors Mohamed S. Alesawy, Ahmed A. Al‐Karmalawy, Eslam B. Elkaeed, Archiv der Pharmazie	2020	74
[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4′,3′-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies Khaled El‐Adl, Mohamed‐Kamal Ibrahim, Mohamed S. Alesawy, Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryNatural SciencesMedicineCoordination Complex	2020	64
Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: molecular modeling and <i>in vitro</i> antiviral screening Abdallah E. Abdallah, Mohamed S. Alesawy, Sally I. Eissa, New Journal of Chemistry EngineeringAntiviral CompoundNovel Benzamide DerivativesBenzamide DerivativesMedicine	2021	59
In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Mohamed S. Alesawy, Abdallah E. Abdallah, Mohammed S. Taghour, Molecules	2021	58
Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors Abdallah E. Abdallah, Reda R. Mabrouk, Maged Mohammed Saleh Al Ward, Journal of Enzyme Inhibition and Medicinal Chemistry	2022	54
In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies Mohamed S. Alesawy, Eslam B. Elkaeed, Aisha A. Alsfouk, Molecules	2021	53
Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs Ibrahim H. Eissa, Mohamed S. Alesawy, Abdulrahman M. Saleh, Molecules	2022	48

Page 1